{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:20:31Z","timestamp":1740144031142,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Welsh Health Specialised Services Committee"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s40258-021-00692-y","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T01:02:24Z","timestamp":1645750944000},"page":"487-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-5066","authenticated-orcid":false,"given":"Edyta","family":"Ryczek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-1410","authenticated-orcid":false,"given":"Susan C.","family":"Peirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-8026","authenticated-orcid":false,"given":"Laura","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-3138","authenticated-orcid":false,"given":"Andrew","family":"Cleves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-0931","authenticated-orcid":false,"given":"Andrew","family":"Champion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-1000","authenticated-orcid":false,"given":"Iolo","family":"Doull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-0925","authenticated-orcid":false,"given":"Sian","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"692_CR1","unstructured":"Dickinson M. NHS Wales specialised services strategy. 2012. https:\/\/whssc.nhs.wales\/publications\/strategies-and-plans\/specialised-services-strategy\/. Accessed 31 Aug 2021."},{"issue":"9","key":"692_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.healthpol.2017.06.007","volume":"121","author":"P Anderson","year":"2017","unstructured":"Anderson P, Webb P, Groves S. Prioritisation of specialist health care services; not NICE, not easy but it can be done. Health Policy. 2017;121(9):978\u201385. https:\/\/doi.org\/10.1016\/j.healthpol.2017.06.007.","journal-title":"Health Policy"},{"key":"692_CR3","unstructured":"WHSSC. An integrated commissioning plan for specialised services for Wales 2020\u20132023. 2020. https:\/\/whssc.nhs.wales\/publications\/integrated-commissioning-plan-2020-2023. Accessed 31 Aug 2021."},{"key":"692_CR4","unstructured":"WHSSC. ICP 2018-2021 Annex 6 WHSSC prioritisation methodology. 2018. https:\/\/whssc.nhs.wales\/publications\/integrated-commissioning-plan-2018-2021\/. Accessed 19 Oct 2021."},{"issue":"4","key":"692_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.mayocp.2018.01.020","volume":"93","author":"A Kanwar","year":"2018","unstructured":"Kanwar A, Thaden JJ, Nkomo VT. Management of patients with aortic valve stenosis. Mayo Clin Proc. 2018;93(4):488\u2013508. https:\/\/doi.org\/10.1016\/j.mayocp.2018.01.020.","journal-title":"Mayo Clin Proc"},{"key":"692_CR6","unstructured":"Healthcare Improvement Scotland. Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults at high surgical risk. Evidence Note 64. 2017. https:\/\/shtg.scot\/our-advice\/transcatheter-aortic-valve-implantation-tavi-for-severe-symptomatic-aortic-stenosis-in-adults-at-high-surgical-risk\/. Accessed 31 Aug 2021."},{"issue":"5","key":"692_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/01.cir.66.5.1105","volume":"66","author":"F Schwarz","year":"1982","unstructured":"Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circ. 1982;66(5):1105\u201310. https:\/\/doi.org\/10.1161\/01.cir.66.5.1105.","journal-title":"Circ"},{"issue":"1","key":"692_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jtcvs.2007.09.011","volume":"135","author":"TM Dewey","year":"2008","unstructured":"Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008;135(1):180\u20137. https:\/\/doi.org\/10.1016\/j.jtcvs.2007.09.011.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"692_CR9","unstructured":"WHSSC. Specialised services policy: CP58. Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis (SSAS). 2012."},{"key":"692_CR10","unstructured":"NHS England. Clinical commissioning policy: transcatheter aortic valve implantation (TAVI) for aortic stenosis (NHSCB\/A09\/P\/a). 2013. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/04\/a09-p-a.pdf. Accessed 31 Aug 2021."},{"key":"692_CR11","unstructured":"National Institute for Health and Care Excellence. Transcatheter aortic valve implantation for aortic stenosis. Interventional procedure guidance (IPG586). 2017. Available from: https:\/\/www.nice.org.uk\/guidance\/ipg586. Accessed 31 Aug 2021."},{"key":"692_CR12","unstructured":"National Institute for Health and Care Excellence. Transcatheter aortic valve implantation for aortic stenosis. Interventional procedure guidance (IPG421). 2012."},{"key":"692_CR13","unstructured":"National Institute for Health and Care Excellence. Acute heart failure: diagnosis and management. Clinical guideline (CG187). 2014. https:\/\/www.nice.org.uk\/guidance\/cg187. Accessed 31 Aug 2021."},{"issue":"1","key":"692_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/S0266462312000670","volume":"29","author":"A Murphy","year":"2013","unstructured":"Murphy A, Fenwick E, Toff WD, Neilson MP, Berry C, Uren N, et al. Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom. Int J Technol Assess Health Care. 2013;29(1):12\u20139. https:\/\/doi.org\/10.1017\/S0266462312000670.","journal-title":"Int J Technol Assess Health Care"},{"issue":"33","key":"692_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17330","volume":"17","author":"R Orlando","year":"2013","unstructured":"Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A, et al. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess. 2013;17(33):1\u201386. https:\/\/doi.org\/10.3310\/hta17330.","journal-title":"Health Technol Assess"},{"issue":"5","key":"692_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/heartjnl-2011-300444","volume":"98","author":"M Watt","year":"2012","unstructured":"Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98(5):370\u20136. https:\/\/doi.org\/10.1136\/heartjnl-2011-300444.","journal-title":"Heart"},{"issue":"13","key":"692_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/heartjnl-2013-303722","volume":"99","author":"TA Fairbairn","year":"2013","unstructured":"Fairbairn TA, Meads DM, Hulme C, Mather AN, Plein S, Blackman DJ, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99(13):914\u201320. https:\/\/doi.org\/10.1136\/heartjnl-2013-303722.","journal-title":"Heart"},{"key":"692_CR18","unstructured":"Scottish Health Technologies Group. Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults at high surgical risk: advice statement 001-17. 2017. https:\/\/shtg.scot\/our-advice\/transcatheter-aortic-valve-implantation-tavi-for-severe-symptomatic-aortic-stenosis-in-adults-at-high-surgical-risk\/. Accessed 31 Aug 2021."},{"issue":"36","key":"692_CR19","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, ESC Scientific Document Group, et al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739\u201391. https:\/\/doi.org\/10.1093\/eurheartj\/ehx391.","journal-title":"Eur Heart J"},{"issue":"22","key":"692_CR20","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1161\/CIR.0000000000000031","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57-185. https:\/\/doi.org\/10.1161\/CIR.0000000000000031.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"692_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0465-6","volume":"13","author":"AC Tricco","year":"2015","unstructured":"Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, et al. A scoping review of rapid review methods. BMC Med. 2015;13(1):1\u20135. https:\/\/doi.org\/10.1186\/s12916-015-0465-6.","journal-title":"BMC Med"},{"key":"692_CR22","unstructured":"National Institute for Health and Care Excellence. Interventional procedure overview of transcatheter aortic valve implantation for aortic stenosis. 2017. https:\/\/www.nice.org.uk\/guidance\/ipg586\/evidence\/overview-final-pdf-4541961565. Accessed 31 Aug 2021."},{"issue":"1","key":"692_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000414","volume":"3","author":"PM Freeman","year":"2016","unstructured":"Freeman PM, Protty MB, Aldalati O, Lacey A, King W, Anderson RA, et al. Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI): a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data. Open Heart. 2016;3(1): e000414. https:\/\/doi.org\/10.1136\/openhrt-2016-000414.","journal-title":"Open Heart."},{"issue":"1","key":"692_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000155","volume":"1","author":"S Brecker","year":"2014","unstructured":"Brecker S, Mealing S, Padhiar A, Eaton J, Sculpher M, Busca R, et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart. 2014;1(1): e000155. https:\/\/doi.org\/10.1136\/openhrt-2014-000155.","journal-title":"Open Heart."},{"issue":"17","key":"692_CR25","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/nejmoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597\u2013607. https:\/\/doi.org\/10.1056\/nejmoa1008232.","journal-title":"N Engl J Med"},{"issue":"9986","key":"692_CR26","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(15)60290-2.","journal-title":"Lancet"},{"issue":"23","key":"692_CR27","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Eng J Med. 2011;364(23):2187\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1103510.","journal-title":"N Eng J Med"},{"issue":"9986","key":"692_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","volume":"385","author":"MJ Mack","year":"2015","unstructured":"Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(15)60308-7.","journal-title":"Lancet"},{"issue":"19","key":"692_CR29","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","volume":"370","author":"DH Adams","year":"2014","unstructured":"Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Eng J Med. 2014;370(19):1790\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1400590.","journal-title":"N Eng J Med"},{"issue":"22","key":"692_CR30","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.jacc.2016.03.506","volume":"67","author":"GM Deeb","year":"2016","unstructured":"Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67(22):2565\u201374. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.506.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"692_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jtcvs.2016.02.073","volume":"152","author":"TG Gleason","year":"2016","unstructured":"Gleason TG, Schindler JT, Adams DH, Reardon MJ, Kleiman NS, Caplan LR, et al. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2016;152(1):85\u201396. https:\/\/doi.org\/10.1016\/j.jtcvs.2016.02.073.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"692_CR32","unstructured":"WHSSC. Consultation guide for commissioning policies and service specifications (054b). 2015. https:\/\/whssc.nhs.wales\/publications\/corporate-policies-and-procedures\/corp054b-consultation-policy\/. Accessed 31 Aug 2021."},{"key":"692_CR33","unstructured":"WHSSC. Specialised services commissioning policy: CP58. Trans-catheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis (SSAS). 2019. https:\/\/whssc.nhs.wales\/commissioning\/whssc-policies\/cardiac\/cp58-trans-catheter-aortic-valve-implantation-tavi-for-severe-symptomatic-aortic-stenosis-ssas-pdf\/. Accessed 31 Aug 2021."},{"key":"692_CR34","unstructured":"WHSSC. An integrated commissioning plan for specialised services for Wales 2019 \u2013 2022. 2019. https:\/\/whssc.nhs.wales\/publications\/integrated-commissioning-plan-2019-2022\/. Accessed 31 Aug 2021."},{"key":"692_CR35","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP III, Gentile F, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-227. https:\/\/doi.org\/10.1161\/CIR.0000000000000923.","journal-title":"Circulation"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-021-00692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-021-00692-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-021-00692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T18:06:30Z","timestamp":1655661990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-021-00692-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1007\/s40258-021-00692-y","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"type":"print","value":"1175-5652"},{"type":"electronic","value":"1179-1896"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"assertion":[{"value":"21 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Cedar, a department within the Cardiff and Vale University Health Board, receives funding from WHSSC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Andrew Champion, Iolo Doull and Sian Lewis are employees of WHSSC. No other conflicts of interest exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"ER, AC and LK conducted the RER, with AC, ID and SL providing oversight and liaison with WHSSC. ER and SP substantially drafted the manuscript, with a review of the text by all the authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}